Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

I1F-MC-RHDC

I'm Interested!

Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered with Tirzepatide in Adult Participants with Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)

  • Sex at Birth: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase III
  • Conditions Being Studied: Psoriasis

Study Purpose

The purpose of this research study is to learn more about tirzepatide used with ixekizumab. Tirzepatide is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, or lose weight and keep it off. Tirzepatide is being investigated in this study to see if weight loss improves plaque psoriasis.

Who Can Participate

Age: 18 and older

Principal Investigator
Neil Korman MD PhD
Department/Division
Dermatology (Psoriasis)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

  • UH IRB: SITE00002362
  • StudyID: 2024-01566
  • ClinicalTrials.gov: NCT06588283
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422